Upgrading of the murine cell line Ba/F3

Dr. Joachim Kremerskothen

In March 2024, the ZKBS upgraded the Ba/F3 cell line due to positive detection of reverse transcriptase activity.

Ba/F3 is an IL-3-dependent Pro-B cell line from the mouse, which is a frequently used system in oncology research. Ba/F3 cells are used, among other things, to characterize cellular kinases and their kinase inhibitors.

The origin of the Ba/F3 cell line was initially unclear, as they were originally described as IL-3-dependent pro-B cells derived from the bone marrow of Balb/c mice. However, subsequent genotyping of the Ba/F3 cells revealed that they were actually isolated from a C3H mouse.

In recent analyses (PCR and ELISA tests) in the laboratories of the German Collection of Microorganisms and Cell Cultures (DSMZ), the activity of a reverse transcriptase in Ba/F3 cell lysates. This result indicates the presence of a previously unidentified endogenous Retrovirus in the cells. As a consequence, the ZKBS has transferred the cell line to the Risk group 2 upgraded. For re-evaluation, the ZKBS may receive its own data on the characterization of the endogenous retrovirus from Ba/F3 cells in the future.

The information on Upgrade of the Ba/F3 cell line can be found on the ZKBS website or in the corresponding Cell line database entry can be retrieved.

Back to blog

More articles in the AGCT Genetic Engineering report